DPP-IV inhibitor (BF = 0.8182): the strongest DPP-IV inhibition among the analyzed peptides, suggesting a strong role in glucose metabolism and diabetes control; ACE inhibitor (BF = 0.1818): low potential in cardiovascular regulation. This evidence concerns the gene ACE and diabetes mellitus.